gastroenterology Conference | bile juice event| Paris |2025

Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academies Conferences

Theme

Digestive Diseases in a Changing World: Tackling Emerging Challenges

- Gastroenterology 2025

Welcome Message

Dear Esteemed Colleagues,

We are delighted to welcome you to the 5th International Conference on Gastroenterology and Digestive Disorders, scheduled to take place on January 27-28, 2025, in Paris, France. This prestigious event will revolve around the theme: “Advancing Research and Therapeutics in Gastroenterology and Digestive Health.”

This Gastroenterology 2025 serves as a unique platform, bringing together renowned speakers, leading researchers, esteemed healthcare professionals, and industry experts from around the globe. Gastroenterology 2025 will feature engaging seminars, symposiums, and workshops highlighting the latest therapeutic advancements in digestive disorders, alongside insightful talks by prominent surgeons, gastroenterologists, endocrinologists, and emerging young researchers.

Key highlights of the event include:

Sessions on cutting-edge research and treatments for digestive disorders.
Opportunities for academic and industry collaboration.
Networking with international experts and peers in the field.

Gastroenterology 2025 is an exceptional opportunity for delegates to exchange ideas, gain new perspectives, and foster professional growth. Whether you are an academic, a healthcare professional, or part of the industry, this event promises to provide invaluable insights and connections.

We encourage you to join us and bring along your colleagues to be part of this remarkable academic gathering. Together, let’s explore the future of gastroenterology while enjoying the enchanting city of Paris, France.

We look forward to welcoming you to this exciting event in January 2025!

Warm regards,
Anna Ruby
Organizing Committee

Market Analysis

MARKET ANALYSIS

The gastroenterology and digestive disorders market is growing due to the increasing prevalence of gastrointestinal diseases and the rising demand for effective treatments. Here are some insights from market analysis reports:

Gastroenterology market

The global gastroenterology market is expected to grow from $32.58 billion in 2022 to $55.04 billion by 2031, with a compound annual growth rate (CAGR) of 6%. The United States is expected to generate the highest revenue in this sector.

Gastrointestinal diseases market

The global gastrointestinal diseases market was valued at $23.28 billion in 2022 and is expected to grow to nearly $36.90 billion by 2029.

Digestive and intestinal remedies market

This market includes over-the-counter remedies for gastrointestinal complaints, such as pills, capsules, liquids, and suppositories. The market is driven by the rising incidence of gastrointestinal diseases, such as GERD, IBS, and peptic ulcers.

Gastrointestinal diagnostics market

The market is growing due to factors such as innovations in diagnostic technologies, the demand for non-invasive diagnostic approaches, and the focus on early detection. The PCR segment is expected to account for 25.6% of the market in 2024. The ELISA segment is expected to show the fastest CAGR during the forecast period

Abstract Submission

Abstract Guidelines for Gastroenterology and Digestive Disorders

The presenting author is requested to ensure that the contact details are valid. The abstract should contain the main author's name followed by the respective co-authors with their affiliations.

The abstract should have a suitable title that clearly reflects the content.
The abstract must be a minimum of 300 words.
The presenting author should also attach a biography and photograph.

To check the scientific session, click on the "Call for Abstracts."

All submitted abstracts will be reviewed. The acknowledgment and Abstract Acceptance Letter will be provided only to the selected abstracts for the Gastroenterology and Digestive Disorders Conference.

For reference, download the sample abstract template and submit your abstract at:
Submit Abstract Here

Alternatively, the presenter can also send the abstract to: [email protected]

To register for the Gastroenterology and Digestive Disorders Conference, click here:
Register Here

Discounts are available for Group Registration. To obtain the discount code, please contact:
Anna Ruby and Email: [email protected]

About Conference

The 5th International Conference on Gastroenterology and Digestive Disorders will be held in Paris, France, on January 27-28, 2025. This conference aims to bring together experts, researchers, clinicians, and practitioners from around the world to share knowledge, advancements, and innovations in the field of gastroenterology and digestive health.

Key Features of the Conference:

Scientific Sessions
Networking Opportunities
Workshops and Symposia
Poster Presentations and Abstract Submissions
Clinical Insights

Conference Goals:

Foster a deeper understanding of gastroenterological disorders and new treatment approaches.
Discuss the latest breakthroughs in medical research and clinical applications.
Provide a platform for researchers to present their findings and collaborate with industry professionals.
Enhance the clinical skills of attendees through engaging workshops and interactive sessions.

For those interested in attending or submitting abstracts, further details about registration, call for abstracts, and submission deadlines will be available closer to the conference date.

Be sure to mark your calendars for this exciting event in the heart of Paris, a city known for its rich history and vibrant culture, making it an ideal setting for scientific exchange and collaboration in the medical field.

Scientific Sessions

Session Track 1: Advances in Gastroenterology

Advances in gastroenterology have revolutionized the diagnosis and treatment of digestive disorders, incorporating cutting-edge technologies like AI and endoscopic innovations. Early detection methods for gastrointestinal cancers are improving survival rates, while personalized treatments are enhancing patient outcomes. The integration of microbiome research is opening new frontiers in gut health management. Ongoing developments in minimally invasive procedures offer safer, more effective solutions for various digestive conditions.

Track 1-1: Gastrointestinal Cancers and Tumor Markers
Track 1-2: Inflammatory Bowel Disease (IBD) and Immunotherapy
Track 1-3: Liver Diseases and Hepatology
Track 1-4: Endoscopic Innovations and Techniques
Track 1-5: Microbiome and Gut Health
Track 1-6: Pediatric Gastroenterology

Associated Journals:

Related Association:

American Gastroenterological Association (AGA) | European Society of Gastrointestinal Endoscopy (ESGE) | World Gastroenterology Organisation (WGO) | Asian Pacific Association of Gastroenterology (APAGE) | British Society of Gastroenterology (BSG) | Canadian Association of Gastroenterology (CAG) | International Association for the Study of the Liver (IASL) | American Society for Gastrointestinal Endoscopy (ASGE) | European Crohn’s and Colitis Organisation (ECCO) | Indian Society of Gastroenterology (ISG)

Related Conference:

United European Gastroenterology (UEG) Week| Digestive Disease Week (DDW) | European Association for the Study of the Liver (EASL) Congress | Asian Pacific Digestive Week (APDW) | International Liver Congress (ILC) | Gastroenterology and Hepatology Congress | World Gastroenterology Summit | Annual Meeting of the American College of Gastroenterology (ACG) | International Conference on Hepatology and Gastroenterology| European Crohn’s and Colitis Organisation (ECCO) Congress

Associated Societies:

World Gastroenterology Organisation (WGO) | International Society of Gastroenterology (ISG)| Federation of Neurogastroenterology and Motility (FNM) | International Association for the Study of the Liver (IASL) | International Society for Diseases of the Esophagus (ISDE) | European Society of Gastrointestinal Endoscopy (ESGE) | Asian Pacific Association of Gastroenterology (APAGE) | Pan-Arab Association of Gastroenterology (PAAG) | Latin American Association for the Study of the Liver (ALEH) | African Middle East Association of Gastroenterology (AMAGE)

Session Track 2: Digestive Disorders: Current Trends

Current trends in digestive disorders focus on precision medicine, where treatments are tailored to individual genetic and microbiome profiles for better outcomes. Advancements in non-invasive diagnostic tools, like advanced imaging and biomarkers, are enhancing early detection. Innovations in pharmacology are providing targeted therapies for chronic conditions such as IBD and GERD. Furthermore, the integration of digital health technologies is transforming patient monitoring and management in real-time.

Track 2-1: GI Cancers & Tumor Markers
Track 2-2: IBD & Immunotherapy
Track 2-3: Liver Diseases & Hepatology
Track 2-4: Endoscopic Techniques
Track 2-5: Microbiome & Gut Health

Associated Journals:

Related Association:

Pan Arab Association of Gastroenterology (PAAG)| Asian Pacific Society for Digestive Endoscopy (APSDE) | Society of American Gastrointestinal and Endoscopic Surgeons (SAGES)| Australasian Society of Clinical Immunology and Allergy (ASCIA)| Latin American Association for the Study of the Liver (ALEH) | American College of Gastroenterology (ACG) | European Association for the Study of the Liver (EASL)| International Foundation for Gastrointestinal Disorders (IFFGD) | Federation of Neurogastroenterology and Motility (FNM) | Society of Gastrointestinal Oncology (SOGO)

Related Conference:

World Endoscopy Organization (WEO) Symposium | American Association for the Study of Liver Diseases (AASLD) Annual Meeting | Asia-Pacific Association for Gastroenterology (APAGE) Annual Conference | International Society of Gastrointestinal Oncology (ISGIO) Annual Meeting | Federation of Neurogastroenterology and Motility (FNM) Biennial Meeting | Canadian Digestive Diseases Week (CDDW) | International Congress of Gastroenterology and Hepatology | World Congress on Digestive Diseases | International Workshop on Advanced Endoscopy | Pan-Arab Gastroenterology Conference

Associated Societies:

American Gastroenterological Association (AGA) | British Society of Gastroenterology (BSG)| Canadian Association of Gastroenterology (CAG)| Indian Society of Gastroenterology (ISG)| Australian Gastroenterology Society (AGS)| European Crohn’s and Colitis Organisation (ECCO)| Crohn's & Colitis Foundation | Celiac Disease Foundation | International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) | Global Liver Institute (GLI)

Session Track 3: Inflammatory Bowel Disease (IBD)

Inflammatory Bowel Disease (IBD), including Crohn's disease and ulcerative colitis, is a chronic inflammatory condition of the digestive tract. Advances in early diagnosis through biomarkers and imaging are improving treatment outcomes. Precision medicine and biologics are providing targeted therapies, reducing disease flare-ups. The gut microbiome is also playing a crucial role in disease progression and treatment response.

Track 3-1: Advances in IBD Diagnosis
Track 3-2: Biologics and Immunotherapy in IBD
Track 3-3: Precision Medicine for IBD
Track 3-4: Microbiome and IBD
Track 3-5: Surgical Management of IBD

Associated Journals:

Related Association:

Related Conference:

Associated Societies:

Session Track 4: Irritable Bowel Syndrome (IBS)

Irritable Bowel Syndrome (IBS) is a common gastrointestinal disorder characterized by abdominal pain, bloating, and changes in bowel habits. It is often triggered by stress, diet, or gut sensitivity. Advances in treatment focus on dietary modifications, gut microbiome interventions, and psychological therapies. New pharmacological approaches are emerging to target specific symptoms like pain and bloating.

Track 4-1: Diagnosis and Symptom Management of IBS
Track 4-2: Dietary Interventions for IBS
Track 4-3: Gut Microbiome and IBS
Track 4-4: Pharmacological Treatments for IBS
Track 4-5: Psychological Approaches in IBS Management

Associated Journals:

Related Association:

Related Conference:

Associated Societies:

Session Track 5: Hepatology and Liver Diseases

Hepatology focuses on the diagnosis and treatment of liver diseases such as hepatitis, cirrhosis, and liver cancer. Advances in molecular medicine and liver transplantation have significantly improved outcomes for patients with severe liver conditions. Early detection through biomarkers and imaging techniques is enhancing liver disease management. Novel therapies, including targeted treatments and immunotherapy, offer hope for better control of liver diseases.

Track 5-1: Hepatitis Diagnosis and Management
Track 5-2: Liver Transplantation and Regenerative Medicine
Track 5-3: Liver Cancer (Hepatocellular Carcinoma)
Track 5-4: Non-Alcoholic Fatty Liver Disease (NAFLD)
Track 5-5: Advances in Hepatology Pharmacology

Associated Journals:

Related Association:

Related Conference:

Associated Societies:

Session Track 6: Gut Microbiome in Health and Disease

The gut microbiome plays a critical role in maintaining digestive health and influencing overall well-being. Imbalances in the microbiome are linked to various diseases, including inflammatory bowel disease, obesity, and metabolic disorders. Advances in microbiome research are revealing new therapeutic targets for gut-related conditions. Modulating the microbiome through diet, probiotics, and antibiotics offers promising strategies for treating and preventing disease.

Track 6-1: Microbiome and Digestive Health
Track 6-2: Dysbiosis and Disease Development
Track 6-3: Gut Microbiome in Inflammatory Bowel Disease
Track 6-4: Microbiome and Metabolic Disorders
Track 6-5: Microbiome-based Therapies

Associated Journals:

Related Association:

Related Conference:

Associated Societies:

Session Track 7: Pancreatic Disorders

Pancreatic disorders, including pancreatitis, pancreatic cancer, and cystic fibrosis, affect both digestive and endocrine functions. Early detection through imaging and biomarkers is improving prognosis for pancreatic diseases. Advances in surgical techniques and targeted therapies are enhancing treatment outcomes. Research into genetic factors and personalized medicine is paving the way for more effective management of pancreatic conditions.

Track 7-1: Pancreatitis: Acute and Chronic Management
Track 7-2: Pancreatic Cancer: Diagnosis and Treatment
Track 7-3: Genetic Factors in Pancreatic Disorders
Track 7-4: Endoscopic Approaches in Pancreatic Disease
Track 7-5: Pancreatic Enzyme Replacement Therapy

Associated Journals:

Related Association:

Related Conference:

Associated Societies:

Session Track 8: Esophageal Disorders

Esophageal disorders, including gastroesophageal reflux disease (GERD), achalasia, and esophageal cancer, affect swallowing and digestive function. Advances in diagnostic techniques like high-resolution manometry and pH monitoring are improving diagnosis. Minimally invasive surgical options and novel medications offer more effective treatments. Ongoing research is focusing on better understanding the pathophysiology and developing personalized therapies for esophageal conditions.

Track 8-1: Gastroesophageal Reflux Disease (GERD)
Track 8-2: Esophageal Cancer: Diagnosis and Treatment
Track 8-3: Achalasia and Esophageal Motility Disorders
Track 8-4: Endoscopic Techniques for Esophageal Disorders
Track 8-5: Esophageal Strictures and Dilatation

Associated Journals:

Related Association:

Related Conference:

Associated Societies:

Session Track 9: Colorectal Cancer

Colorectal cancer is one of the leading causes of cancer-related deaths globally, often linked to lifestyle factors and genetic predisposition. Early detection through screening methods like colonoscopy and stool tests has significantly improved survival rates. Advances in targeted therapies, immunotherapy, and precision medicine are revolutionizing treatment options. Ongoing research focuses on identifying biomarkers for early diagnosis and improving personalized treatments.

Track 9-1: Early Detection and Screening Methods
Track 9-2: Molecular and Genetic Markers in Colorectal Cancer
Track 9-3: Advances in Colorectal Cancer Surgery
Track 9-4: Targeted Therapies in Colorectal Cancer
Track 9-5: Immunotherapy for Colorectal Cancer

Associated Journals:

Related Association:

Related Conference:

Associated Societies:

Session Track 10: Pediatric Gastroenterology

Pediatric gastroenterology focuses on diagnosing and treating digestive disorders in children, including conditions like irritable bowel syndrome (IBS), celiac disease, and liver disorders. Early intervention and tailored therapies are crucial for managing these conditions in younger populations. Advances in non-invasive diagnostic tools and personalized treatments are improving outcomes. Research into genetic factors and the gut microbiome is enhancing our understanding of pediatric gastrointestinal health.

Track 10-1: Pediatric Gastrointestinal Disorders Diagnosis
Track 10-2: Inflammatory Bowel Disease in Children
Track 10-3: Celiac Disease and Gluten Sensitivity
Track 10-4: Liver Diseases in Pediatrics
Track 10-5: Pediatric Nutrition and Digestive Health

Associated Journals:

Related Association:

Related Conference:

Associated Societies:

Session Track 11: Endoscopy: Techniques and Innovations

Endoscopy techniques have revolutionized the diagnosis and treatment of gastrointestinal disorders by providing minimally invasive options for visualization and intervention. Innovations such as capsule endoscopy, robotic-assisted procedures, and advanced imaging technologies are enhancing precision and patient outcomes. New developments in therapeutic endoscopy allow for more effective treatments of conditions like bleeding, strictures, and tumors. Ongoing research is focused on improving the safety, efficiency, and accessibility of endoscopic procedures.

Track 11-1: Robotic-Assisted Endoscopy
Track 11-2: Endoscopic Ultrasound (EUS)
Track 11-3: Innovations in Imaging for Endoscopy
Track 11-4: Therapeutic Endoscopy: Treatment of GI Disorders
Track 11-5: Capsule Endoscopy: Applications and Advancements

Associated Journals:

Related Association:

Related Conference:

Associated Societies:

Session Track 12: Celiac Disease and Gluten-Related Disorders

Celiac disease is an autoimmune disorder where the ingestion of gluten triggers an immune response that damages the small intestine. Recent advancements in diagnosis, including genetic testing and biomarker identification, have improved early detection. Gluten-related disorders, such as non-celiac gluten sensitivity, are also gaining attention, though their mechanisms remain less understood. Ongoing research is focused on developing more effective treatments and potential therapies beyond the gluten-free diet.

Track 12-1: Diagnosis and Biomarkers in Celiac Disease
Track 12-2: Gluten-Free Diet: Challenges and Solutions
Track 12-3: Non-Celiac Gluten Sensitivity
Track 12-4: Genetic and Environmental Factors in Celiac Disease
Track 12-5: Pediatric Celiac Disease

Associated Journals:

Related Association:

Related Conference:

Associated Societies:

Session Track 13: Obesity and Bariatric Gastroenterology

Obesity and bariatric gastroenterology focus on managing obesity through medical and surgical approaches. Bariatric surgeries like gastric bypass and sleeve gastrectomy are key treatments for severe obesity. Non-surgical options, including pharmacological treatments and endoscopic procedures, are also emerging. Research is exploring the role of the gut microbiome and digestive hormones in weight management and metabolic health.

Track 13-1: Bariatric Surgery Techniques and Innovations
Track 13-2: Non-Surgical Weight Loss Interventions
Track 13-3: Gut Microbiome and Obesity
Track 13-4: Pharmacological Treatments for Obesity
Track 13-5: Metabolic Effects of Bariatric Surgery

Associated Journals:

Related Association:

Related Conference:

Associated Societies:

Session Track 14: Gastrointestinal Motility Disorders

Gastrointestinal motility disorders involve abnormal movement of the digestive tract, leading to symptoms like bloating, constipation, and abdominal pain. Conditions such as gastroparesis, achalasia, and irritable bowel syndrome (IBS) fall under this category. Advances in diagnostic tools like manometry and imaging are improving detection. New treatments, including prokinetic medications and neuromodulation therapies, are enhancing management and patient outcomes.

Track 14-1: Gastroparesis: Diagnosis and Management
Track 14-2: Achalasia and Esophageal Motility Disorders
Track 14-3: Irritable Bowel Syndrome (IBS) and Motility
Track 14-4: Chronic Constipation and Motility Dysfunction
Track 14-5: Small Bowel Motility Disorders

Associated Journals:

Related Association:

Related Conference:

Associated Societies:

Session Track 15: Alcohol-Related Digestive Disorders

Alcohol-related digestive disorders include conditions like alcoholic liver disease, pancreatitis, and gastritis, caused by excessive alcohol consumption. These disorders can lead to inflammation, organ damage, and impaired digestive function. Early diagnosis and intervention are crucial in preventing long-term complications. Management focuses on abstinence, nutritional support, and medical treatments tailored to the severity of the disorder.

Track 15-1: Alcoholic Liver Disease: Diagnosis and Treatment
Track 15-2: Alcoholic Pancreatitis and its Management
Track 15-3: Gastritis and Gastroesophageal Reflux Disease (GERD) Due to Alcohol
Track 15-4: Alcohol and Its Impact on the Gut Microbiome
Track 15-5: Nutritional Management in Alcohol-Related Disorders

Associated Journals:

Related Association:

Related Conference:

Associated Societies:

Session Track 16: Parasitic and Infectious Gastrointestinal Diseases

Parasitic and infectious gastrointestinal diseases are caused by pathogens like bacteria, viruses, and parasites, leading to symptoms such as diarrhea, vomiting, and abdominal pain. Common conditions include giardiasis, amoebiasis, and bacterial infections like Salmonella and E. coli. Advances in diagnostics are improving the identification of these infections through molecular techniques. Treatment often involves antibiotics, antiparasitic medications, and hydration therapy, with prevention strategies focusing on hygiene and sanitation.

Track 16-1: Viral Gastroenteritis and Enteric Infections
Track 16-2: Parasitic Infections: Giardiasis, Amoebiasis, and Others
Track 16-3: Diagnosis of Infectious GI Diseases: Molecular Techniques
Track 16-4: Foodborne Infections and Public Health
Track 16-5: Travel-Related Gastrointestinal Diseases

Associated Journals:

Related Association:

Related Conference:

Associated Societies:

Session Track 17: Nutritional Aspects in Gastroenterology

Nutritional aspects in gastroenterology focus on the role of diet in managing gastrointestinal disorders such as IBS, Crohn's disease, and celiac disease. Proper nutrition is essential for preventing malnutrition, supporting healing, and improving gut health. Tailored dietary interventions, including fiber, probiotics, and specific food restrictions, are key components in treatment. Research continues to explore the relationship between the gut microbiome, diet, and digestive disorders for better outcomes.

Track 17-1: Diet in IBD
Track 17-2: Celiac Disease Nutrition
Track 17-3: Probiotics and Prebiotics
Track 17-4: Gut Microbiome and Diet
Track 17-5: Malnutrition in GI Disorders
Track 17-6: Gluten-Free Diet

Associated Journals:

Related Association:

Related Conference:

Associated Societies:

Session Track 18: Gastrointestinal Oncology

Gastrointestinal oncology focuses on the diagnosis, treatment, and management of cancers affecting the digestive system, including colorectal, esophageal, and gastric cancers. Early detection through screening and advanced imaging techniques is crucial for improving survival rates. Targeted therapies, immunotherapy, and precision medicine are transforming treatment approaches. Ongoing research aims to identify biomarkers and develop novel treatments for better outcomes in GI cancer patients.

Track 18-1: Colorectal Cancer: Diagnosis and Treatment
Track 18-2: Esophageal Cancer: Advances in Management
Track 18-3: Gastric Cancer: Early Detection and Therapy
Track 18-4: Liver Cancer: Hepatocellular Carcinoma
Track 18-5: Pancreatic Cancer: Innovations in Treatment

Associated Journals:

Related Association:

Related Conference:

Associated Societies:

Session Track 19: Acid-Related Disorders

Acid-related disorders, such as gastroesophageal reflux disease (GERD), peptic ulcers, and Zollinger-Ellison syndrome, occur due to imbalances in stomach acid production. These conditions cause symptoms like heartburn, indigestion, and stomach pain. Treatment typically involves acid-suppressing medications like proton pump inhibitors (PPIs) and lifestyle modifications. Ongoing research focuses on improving drug therapies and understanding the underlying causes of acid-related disorders.

Track 19-1: Gastroesophageal Reflux Disease (GERD)
Track 19-2: Peptic Ulcers: Diagnosis and Management
Track 19-3: Zollinger-Ellison Syndrome
Track 19-4: Proton Pump Inhibitors (PPIs) and Other Treatments
Track 19-5: Lifestyle Modifications in Acid-Related Disorders

Associated Journals:

Related Association:

Related Conference:

Associated Societies:

Session Track 20: Gastrointestinal Surgery

Gastrointestinal surgery involves surgical interventions to treat digestive system disorders, including conditions like colorectal cancer, Crohn's disease, and gallbladder disease. Advances in minimally invasive techniques, such as laparoscopy and robotic surgery, have improved recovery times and reduced complications. These surgeries often aim to remove tumors, correct blockages, or repair damaged organs. Ongoing research focuses on enhancing surgical techniques and patient outcomes in gastrointestinal procedures.

Track 20-1: Minimally Invasive Gastrointestinal Surgery
Track 20-2: Laparoscopic and Robotic Surgery in GI Disorders
Track 20-3: Surgical Approaches in Colorectal Cancer
Track 20-4: Bariatric Surgery: Techniques and Innovations
Track 20-5: Surgery for Inflammatory Bowel Disease (IBD)

Associated Journals:

Related Association:

Related Conference:

Associated Societies:

Session Track 21: Biliary Tract Disorders

Biliary tract disorders, including cholecystitis, bile duct obstruction, and cholangitis, affect the liver's ability to process bile, often leading to pain, jaundice, and digestive issues. These conditions are commonly caused by gallstones, infections, or tumors. Treatment may involve medications, endoscopic procedures, or surgery, depending on the severity. Advances in imaging and minimally invasive techniques are improving diagnosis and treatment outcomes.

Track 21-1: Cholecystitis: Diagnosis and Management
Track 21-2: Gallstones and Biliary Colic
Track 21-3: Bile Duct Obstruction and Strictures
Track 21-4: Cholangiocarcinoma: Diagnosis and Treatment
Track 21-5: Laparoscopic Surgery for Biliary Tract Disorders

Associated Journals:

Related Association:

Related Conference:

Associated Societies:

Session Track 22: Genetic and Rare Digestive Disorders

Genetic and rare digestive disorders are caused by inherited mutations that affect the gastrointestinal system, such as cystic fibrosis, familial adenomatous polyposis, and hereditary pancreatitis. These conditions often require specialized care due to their complex nature and impact on digestion. Advances in genetic testing are improving early diagnosis and personalized treatment. On-going research is focused on gene therapies and better management strategies for these rare conditions.

Track 22-1: Cystic Fibrosis and Gastrointestinal Manifestations
Track 22-2: Hereditary Gastrointestinal Cancers (e.g., Familial Adenomatous Polyposis)
Track 22-3: Genetic Causes of Pancreatitis
Track 22-4: Inherited Metabolic Disorders Affecting Digestion
Track 22-5: Genetic Testing in Gastrointestinal Diseases

Associated Journals:

Related Association:

Related Conference:

Associated Societies:

Session Track 23: GI Tract Imaging

GI tract imaging is essential for diagnosing and monitoring digestive disorders, offering non-invasive methods to visualize abnormalities. Techniques like endoscopy, CT scans, MRI, and ultrasound are used to detect conditions such as tumors, inflammations, and blockages. Advances in imaging technologies are enhancing resolution and precision for better diagnostics. Ongoing developments focus on improving image quality, reducing radiation exposure, and increasing accessibility.

Track 23-1: Endoscopic Imaging: Techniques and Innovations
Track 23-2: CT and MRI Imaging in Gastrointestinal Disorders
Track 23-3: Ultrasound Imaging in Gastroenterology
Track 23-4: Functional Imaging in GI Diseases
Track 23-5: Advanced Imaging for GI Cancer Detection

Associated Journals:

Related Association:

Related Conference:

Associated Societies:

Session Track 24: Pharmacology in Gastroenterology

Pharmacology in gastroenterology focuses on the use of medications to treat digestive system disorders, including acid-related diseases, IBD, and infections. Drugs like proton pump inhibitors, biologics, and antibiotics are commonly used for managing conditions. Advances in pharmacology are leading to more targeted therapies with fewer side effects. Ongoing research aims to develop new treatments that address the underlying causes of gastrointestinal diseases.

Track 24-1: Pharmacological Treatment of Inflammatory Bowel Disease (IBD)
Track 24-2: Proton Pump Inhibitors and Acid-Related Disorders
Track 24-3: Biologics and Immunotherapy in Gastrointestinal Diseases
Track 24-4: Antibiotic Use in Gastrointestinal Infections
Track 24-5: Pharmacological Management of Hepatic Disorders

Associated Journals:

Related Association:

Related Conference:

Associated Societies:

Session Track 25: Post-Surgical Gastroenterology

Post-surgical gastroenterology focuses on the management and recovery of patients after gastrointestinal surgery. This includes monitoring for complications like infection, anastomotic leakage, and gastrointestinal motility issues. Nutritional support and pain management are key components of post-surgical care. Advances in minimally invasive techniques and faster recovery protocols are improving patient outcomes and reducing hospital stays.

Track 25-1: Post-Surgical Complications in Gastrointestinal Surgery
Track 25-2: Nutritional Support and Management After GI Surgery
Track 25-3: Pain Management in Post-Surgical Gastroenterology
Track 25-4: Recovery and Rehabilitation Following Gastrointestinal Procedures
Track 25-5: Gastrointestinal Motility Disorders After Surgery

Associated Journals:

Related Association: